| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Johnson & Johnson is focused on corporate innovation and growth, significantly enhancing its product portfolio with a renewed confidence in product functionality after recent rollouts. While the potential of nipocalimab is promising, underscoring the company's innovative efforts, challenges in vaccine development have negatively impacted its product development trajectory. The need for continued focus on overcoming these challenges is essential for future growth potential in a competitive market. Positive developments in product launches could provide the necessary momentum for Johnson & Johnson to regain market positioning. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.2 on 2025-02-18. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (1.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| JNJ | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| 2025-02-14 | 0%(0%) | 0 | 0% | 0 | 1.1 | -1 | |||||||
| 2025-02-12 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-02-11 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -1 | |||||||
| 2025-02-10 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-02-05 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-01-31 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -1 | |||||||
| 2025-01-28 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-01-16 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-01-10 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-06-11 22:27:53 Johnson & Johnson's strong market position and competitive advantages through diversification and financial stability are discussed. |
| 2025-06-11 22:27:53 The decision-making process regarding product developments and partnerships indicates the leadership's focus on strategic growth. |
| 2025-06-11 22:27:53 Articles highlight Johnson & Johnson's commitment to innovation and growth within its product portfolio and pipelines. |
| 2025-06-11 22:27:53 Discussions around Genmab's positive financial growth and J&J's robust earnings indicate a favorable outlook for the companies’ financial health. |
| 2025-06-11 22:27:53 Several articles discuss ongoing legal issues faced by Johnson & Johnson, particularly concerning lawsuits related to its products, highlighting the difficulties that arise in corporate legal systems. |